Immatics Announces Pricing of $150 Million Public Offering
Houston, Texas and Tuebingen, Germany, October 10, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in […]
Upstream Bio Announces Pricing of Upsized Initial Public Offering
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for […]
Monarch Casino & Resort to Report 2024 Third Quarter Results After Market Close on October 23
RENO, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) — Monarch Casino & Resort, Inc. (NASDAQ: MCRI) announced today that it will […]
CAMP4 Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biotechnology company developing a […]
Rising Dragon Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
SHANXI, CHINA, Oct. 10, 2024 (GLOBE NEWSWIRE) — Rising Dragon Acquisition Corp. (NASDAQ: RDAC) (the “Company”) announced today that it priced […]
Cohen Circle Acquisition Corp. I Announces Pricing of $200,000,000 Initial Public Offering
PHILADELPHIA, PA, Oct. 10, 2024 (GLOBE NEWSWIRE) — Cohen Circle Acquisition Corp. I (NASDAQ:CCIRU) (the “Company”) today announced the pricing […]
AVITA Medical to Announce Third Quarter 2024 Financial Results
VALENCIA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company […]
Click Holdings Limited Announces Closing of Initial Public Offering
Hong Kong, Oct. 10, 2024 (GLOBE NEWSWIRE) — Click Holdings Limited (“CLIK” or the “Company”), a Hong Kong-based human resources […]
Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder
ROCKVILLE, Md., Oct. 10, 2024 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and […]
Clover Health PPO Medicare Advantage Plans Earn 4 Star Rating for 2025
FRANKLIN, Tenn., Oct. 10, 2024 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), […]
